Recombinant Human Transferrin (rhTf)
Optiferrin®
GMP Recombinant human transferrin supplied as a lyophilized powder, delivering and recycling iron in serum-free and chemically defined cell culture media.
Replacing plasma-derived or bovine transferrin with Optiferrin provides lot-to-lot consistency and lowers risk and regulatory complexity. It can also replace iron chelators in serum-free media, delivering iron through the native transferrin receptor pathway.
Composition
- Purity
- >95%
- Endotoxin
- ≤1.0 EU/mg
- Form
- Powder
- Storage
- -20 °C
Compliance
- Expression System
- Recombinant, AOF
- Manufacturing
- cGMP, ISO 9001:2015
- Facility
- Junction City, KS
- Documentation
- Lot-specific CoA
Product overview
A recombinant human transferrin for serum-free, chemically defined media.
Every cell needs iron for DNA synthesis, mitochondrial respiration, and enzymatic activity, and free iron catalyzes Fenton chemistry that damages DNA, proteins, and lipid membranes. Serum-free programs cover that requirement three ways, and each carries a cost. Plasma-derived human transferrin brings donor variability, adventitious agent risk, and the regulatory complexity of blood-sourced materials. Bovine transferrin brings TSE/BSE risk, and herd-to-herd variability. Iron salts and chelators deliver iron without controlling how or where it enters cells.
Optiferrin® is InVitria’s recombinant human transferrin, produced in the ExpressTec™ platform at the ISO 9001:2015-certified, cGMP-compliant facility in Junction City, Kansas.




Featured Resources
The published data behind the claims
Technical specifications
| Attribute | Value |
|---|---|
| Physical & Chemical | |
| Form | Lyophilized powder |
| Total protein | >90% |
| Purity | >95% |
| Endotoxin level | ≤1.0 EU/mg |
| pH | 6.0 to 8.0 |
| Moisture | Listed on Certificate of Analysis |
| Storage conditions | -20 °C |
| Shelf life | 3 years from DOM (powder) |
| Packaging | 1 g, 10 g, 100g |
| Composition | |
| Product name | Optiferrin® |
| SKU / Product Number | 777TRF029 |
| Protein | Recombinant human transferrin (rhTf) |
| Synonyms | rhTf |
| Expression system | Recombinant, Animal-Origin Free |
| Regulatory | |
| Production standard | cGMP-compliant quality management system with respect to 21 CFR Part 210/211 |
| Quality system | ISO 9001:2015-certified facility |
| Country of origin | USA (Junction City, KS) |
| Documentation | Certificate of Analysis (request form) · Data Sheet · Guidelines for Use · Safety Data Sheet · Certificate of Origin and Animal-Free / TSE-BSE Statement · ISO 9001:2015 certificate · cGMP Statement · product-specific Technical Summary on request |
| Peer-reviewed validation | Steere et al. 2012 J Inorg Biochem; Zhang et al. 2012 BMC Biotechnology; Fetterman et al. 2024 Cell Reports |
Key Benefits
- Defined Recombinant Transferrin
- Optiferrin®: >95% purity, ≤1.0 EU/mg endotoxin, supplied as a lyophilized powder.
- Matches Plasma Transferrin in Hybridomas
- Sp2/0 growth matched human plasma transferrin from 0.1 to 10 mg/L in serum-free medium.
- Partially iron-saturated, optimal for cell culture.
- Supplied between pure apo and fully diferric forms. The apo portion scavenges free iron from culture media at K′₁ = 4.7 × 10²⁰ M⁻¹ and converts it into the receptor-delivered form. Iron salts and chelators deliver iron without controlling how it enters cells or how it is recycled to reduce oxidative stress.
- Binds Transferrin Receptor Like Native
- Correct sequence and size; competes with plasma transferrin for TFR1 on CCL-2 and Caco-2 cells.
How to order Optiferrin®
- Catalog purchase
- 1 g at $351.72 and 10 g at $2,177.16 on the InVitria catalog. Both ship as lyophilized powder.
- Purchase Order
- Contact info@invitria.com or a Product Applications team member at InVitria to submit a PO directly.
- Bulk pricing
- Larger quantities are quoted on request through the bulk pricing form. Working directly with InVitria brings volume-tier pricing, faster supply chain turnaround, GMP supply commitments, and bulk and custom packaging for media formulation and biomanufacturing programs.
- Regional distribution
- Optiferrin is available through Fisher Scientific, VWR, and the Labviva procurement platform for institutional procurement systems. European customers can order with direct fulfillment from InVitria’s Rotterdam, Netherlands facility. For other regions, use Find a Distributor.
A Certificate of Analysis is issued for every lot and is available through the request form. The Data Sheet, Guidelines for Use, and Safety Data Sheet are the product’s own downloadable documents, and the Technical Summary is request-only. TSE/BSE statement and Certificate of Origin are published resources.
Common questions
Optiferrin® is InVitria’s recombinant human transferrin, a chemically defined, animal-origin-free iron delivery protein for serum-free cell culture media. It is produced in InVitria’s ExpressTec™ expression platform at an ISO 9001:2015-certified, cGMP-compliant facility in Junction City, Kansas. Optiferrin delivers iron through transferrin receptor-1 (TFR1)-mediated endocytosis, the biologically safe mechanism cells evolved to solve the oxidative damage problem of free iron in culture media.
Transferrin is an iron-binding glycoprotein that delivers iron to cells through the transferrin receptor (TFR1). In cell culture it replaces the iron-carrier function of serum, supporting proliferation and productivity in serum-free and chemically defined media. Cells require iron for DNA synthesis, mitochondrial respiration, and enzymatic activity, but free iron catalyzes oxidative reactions that damage cells. Transferrin sequesters iron safely and delivers it through receptor-mediated endocytosis, which makes it the biologically preferred iron source in serum-free bioprocessing (Luck & Mason, 2012; Kawabata, 2022).
Optiferrin is produced recombinantly on InVitria’s ExpressTec™ expression platform, a non-mammalian, non-human host with no animal-derived, human-derived, or blood-derived materials.
Cells require iron for DNA synthesis, mitochondrial respiration, and enzymatic activity, but free iron (Fe²⁺ and Fe³⁺) catalyzes Fenton chemistry, generating reactive oxygen species that damage DNA, proteins, and lipid membranes (Kawabata, 2022). Iron salts such as iron chloride, ferric ammonium citrate, and iron sulfate deliver iron to the media but do not control how or where it enters cells, exposing cultures to oxidative stress. Iron chelators face similar limitations. They bind iron but do not replicate the controlled, receptor-mediated delivery pathway cells evolved to use. Transferrin-mediated delivery through TFR1-dependent endocytosis is the physiologically correct mechanism. It sequesters iron safely in the media and releases it intracellularly through a controlled endocytic cycle (Luck & Mason, 2012; Lane et al., 2015).
Yes. InVitria manufactures Optiferrin under a cGMP-compliant quality management system with respect to 21 CFR Part 210/211 at its ISO 9001:2015-certified facility in Junction City, Kansas, USA. Optiferrin is 100% animal-origin-free.
Optiferrin is supported by a Certificate of Analysis, Safety Data Sheet, Guidelines for Use, Certificate of Origin and Animal-Free / TSE-BSE Statement, ISO 9001 certificate, and cGMP Statement. Additional quality and regulatory documentation is available on request, including Regulatory Support Files for IND filings and materials for supplier qualification in cell therapy, gene therapy, and biologics production.
InVitria provides a product-specific Technical Summary for Optiferrin containing CMC-style documentation. Contact us to request it.
Optiferrin is produced in a non-mammalian host, which eliminates the risk of human and mammalian pathogen contamination inherent to CHO or human cell-derived proteins. That origin also removes the viral clearance validation steps typically required for mammalian-derived biologics. For process developers this means simpler regulatory filings, lower viral safety risk, and fewer downstream purification burdens than transferrin produced in mammalian cell lines or in yeast systems, which can introduce immunogenic yeast host cell proteins requiring extensive purification.
Optiferrin delivers iron through receptor-mediated endocytosis via transferrin receptor-1 (TFR1), the same mechanism used by plasma-derived transferrin. At physiological pH, iron-bound transferrin binds TFR1 at the cell surface and is internalized through clathrin-dependent endocytosis. Acidification of the endosome releases iron from transferrin, and Fe³⁺ is reduced to Fe²⁺ before export to the cytosol. The iron-free transferrin and TFR1 complex returns to the surface, where apo transferrin dissociates to bind more Fe³⁺ and repeat the cycle. Each full cycle takes roughly 15 to 16 minutes, with approximately 90% of transferrin recycled within 30 minutes (Luck & Mason, 2012).
Optiferrin is structurally and functionally equivalent to plasma-derived human transferrin. It has been analyzed to confirm correct sequence, correct molecular weight, and the ability to compete with human serum-derived transferrin for TFR1 binding sites on CCL-2 and Caco-2 cells (Steere et al., 2012; Zhang et al., 2012). Because Optiferrin is recombinant and non-mammalian in origin, it eliminates the lot variability, pathogen risk, and regulatory burden of plasma-sourced material while delivering equivalent biological activity.
Optiferrin is supplied as an optimized partially iron-saturated transferrin, rather than pure apo (iron-free) or fully holo (diferric) forms. That saturation supports efficient iron delivery and recycling across a wide range of cell culture conditions. The apo portion actively scavenges free iron from culture media with extremely high affinity (K′₁ = 4.7 × 10²⁰ M⁻¹), converting potentially harmful unbound iron in the media into the safe, receptor-delivered form cells prefer.
Yes. Optiferrin is designed as a drop-in replacement for plasma-derived human transferrin and bovine transferrin in serum-free cell culture media supplementation. Unlike bovine transferrin, Optiferrin eliminates TSE/BSE risk and herd-to-herd variability. Unlike plasma-derived human transferrin, it eliminates donor variability, adventitious agent risk, and the regulatory complexity of blood-sourced materials. Substitution can typically be performed at equivalent concentrations when the target transferrin level is known. Optimal concentration for a specific cell type and media formulation can be determined empirically in the 0.1 to 20 mg/L range.
Optiferrin has been validated with hybridomas, T cells, NK cells, VERO cells, mesenchymal stem cells (MSC), neural stem cells, hematopoietic stem cells (HSC), induced pluripotent stem cells (iPSC), hiPSC-derived cardiomyocytes, fibroblasts, and keratinocytes. Typical working concentrations are 0.1 to 10 mg/L, with concentrations up to 20 mg/L used in hiPSC-derived cardiomyocyte maturation protocols.
For most cell types, use Optiferrin at 0.1 to 10 mg/L in serum-free or chemically defined media. For hiPSC-derived cardiomyocyte maturation, concentrations up to 20 mg/L have been used. For transfection enhancement in HEK293T cells, the recommended working concentration is 1 mg/mL during the transfection step. Optimal concentration depends on cell type, media formulation, and culture density. Contact InVitria’s technical team for application-specific guidance.
Yes
Yes. Optiferrin has been cited in peer-reviewed publications across journals including Nature Methods, Nature Medicine, Cell Reports, Molecular Cell, Theranostics, and Scientific Reports. Published applications include chemically defined cardiomyocyte generation from pluripotent stem cells, hiPSC-derived cardiomyocyte maturation, iPSC-derived cardiotoxicity modeling, and iPSC generation from peripheral blood mononuclear cells. The structural and receptor-binding characterization of the protein itself is published in Journal of Inorganic Biochemistry and BMC Biotechnology.
Optiferrin is supplied as a lyophilized powder. The InVitria catalog lists 1 g and 10 g. Contact InVitria for bulk and custom packaging options supporting cell culture media formulation and biomanufacturing programs.
Optiferrin is available worldwide through several purchasing pathways. Most customers work directly with InVitria for full access to the InVitria product portfolio, bulk and commercial-scale supply, favorable volume-tier pricing, faster supply chain turnaround, GMP supply commitments, and regulatory documentation support. Optiferrin is also available through Fisher Scientific, VWR, and the Labviva procurement platform, which integrates with Ariba, Coupa, Oracle, and Jaggaer, for institutional procurement systems that require integrated supplier ordering. UK and European customers can order with direct fulfillment from InVitria’s Rotterdam, Netherlands facility. Every customer receives the same product, Certificate of Analysis, and technical support, whatever the channel. Contact InVitria or request bulk pricing to place an order.
Store Optiferrin at -20 °C in lyophilized form. Reconstitute gently in PBS at 5 to 20 mg/mL, avoid foaming, and filter-sterilize through a 0.2 µm membrane before use. Avoid repeated freeze-thaw cycles. Shelf life is 3 years from date of manufacture. For complete handling instructions, refer to the Optiferrin Guidelines for Use.
Use the Certificate of Analysis request form. A Certificate of Analysis is issued for every lot. Optiferrin is also supported by a Safety Data Sheet, Guidelines for Use, Certificate of Origin and Animal-Free / TSE-BSE Statement, ISO 9001 certificate, and cGMP Statement.
InVitria’s ITS supplements contain recombinant human transferrin produced on the same ExpressTec™ platform as Optiferrin®, pre-formulated with insulin and selenium at fixed ratios. Optiferrin is sold separately for custom ITS formulations, where the transferrin level is set independently. ITS Animal-Free™ is the three-component baseline of insulin, transferrin, and selenium. ITSE Animal-Free® adds ethanolamine. ITSE+A Animal-Free® adds ethanolamine and recombinant human albumin, and is the broadest serum replacement for CAR-T, iPSC, and MSC workflows. Choose Optiferrin when you are formulating the media yourself.
Optiferrin is recombinant human transferrin, used for iron delivery through the transferrin receptor (TFR1). Lacromin® is recombinant human holo-lactoferrin, used for growth-factor-like activity through LRP1 binding and MAPK/ERK signaling, with synergy with FGF2 and EGF. Same protein family, different functional roles. Some formulations use both.
Peer-Reviewed Publications
-
Neuroscience & Organoids
Lipid-driven membrane remodeling engages a lysosome-dependent adaptive repair program during retinal aging
Read paper (DOI) ↗ -
iPSC Culture & Stem Cell Biology
Generation of an induced pluripotent stem cell line, JHUi010-A, from an arrhythmogenic cardiomyopathy patient harboring pathogenic DSG2 variant c.2358delA
Read paper (DOI) ↗ -
Virology & Viral Vectors
Cultures Through Time: Forging a Xeno-Free Future for Cell Culture-Based Virology
Read paper (DOI) ↗ -
Cultivated Meat
Growth factor thermostability dataset derived from experimental and computational approaches to accelerate cultured meat development
Read paper (DOI) ↗ -
iPSC Culture & Stem Cell Biology
Combinatorial and Inducible CRISPRa/i Enables Canalized hiPSC Forward Programming and Iterative Refinement via Single-Cell Genomics
Read paper (DOI) ↗ -
iPSC Culture & Stem Cell Biology
Single cell transcriptional perturbome in pluripotent stem cell models
Read paper (DOI) ↗ -
Neuroscience & Organoids
Dissecting gene regulatory networks governing human cortical cell fate
Read paper (DOI) ↗ -
iPSC Culture & Stem Cell Biology
CellBouncer, a unified toolkit for single-cell demultiplexing and ambient RNA analysis, reveals hominid mitochondrial incompatibilities
Read paper (DOI) ↗ -
iPSC Culture & Stem Cell Biology
Generation of an induced pluripotent stem cell line, JHUi008-A, from a healthy female donor
Read paper (DOI) ↗ -
Cultivated Meat
Animal-derived components in cultivated meat research and their alternatives
Read paper (DOI) ↗ -
Virology & Viral Vectors
Transferrin-binding domain inserted-adenovirus hexon engineering enables systemic immune evasion and intratumoral T-cell activation
Read paper (DOI) ↗ -
Neuroscience & Organoids
A mouse organoid platform for modeling cerebral cortex development and cis-regulatory evolution in vitro
Read paper (DOI) ↗ -
iPSC Culture & Stem Cell Biology
Examining patient-specific responses to PARP inhibitors in a novel, human induced pluripotent stem cell-based model of breast cancer
Read paper (DOI) ↗ -
Cardiomyocytes & Cardiac Models
Independent compartmentalization of functional, metabolic, and transcriptional maturation of hiPSC-derived cardiomyocytes
Read paper (DOI) ↗ -
Neuroscience & Organoids
Thalamocortical organoids enable in vitro modeling of 22q11.2 microdeletion associated with neuropsychiatric disorders
Read paper (DOI) ↗ -
iPSC Culture & Stem Cell Biology
Refined and benchmarked homemade media for cost-effective, weekend-free human pluripotent stem cell culture
Read paper (DOI) ↗ -
Neuroscience & Organoids
Human brain organoids containing microglia that have arisen innately adapt to a β-amyloid challenge better than those in which microglia are integrated by co-culture
Read paper (DOI) ↗ -
Neuroscience & Organoids
Brain organoids engineered to give rise to glia and neural networks after 90 days in culture exhibit human-specific proteoforms
Read paper (DOI) ↗ -
iPSC Culture & Stem Cell Biology
Nutritional requirements of human induced pluripotent stem cells
Read paper (DOI) ↗ -
Cultivated Meat
Continuous fish muscle cell line with capacity for myogenic and adipogenic-like phenotypes
Read paper (DOI) ↗ -
Blood & Hematopoietic Cells
Generation of Red Blood Cells from Human Pluripotent Stem Cells—An Update
Read paper (DOI) ↗ -
iPSC Culture & Stem Cell Biology
Naïve-like pluripotency to pave the way for saving the northern white rhinoceros from extinction
Read paper (DOI) ↗ -
iPSC Culture & Stem Cell Biology
An updated protocol for the cost-effective and weekend-free culture of human induced pluripotent stem cells
Read paper (DOI) ↗ -
Cardiomyocytes & Cardiac Models
RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapy
Read paper (DOI) ↗ -
Cardiomyocytes & Cardiac Models
Scalable Generation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Read paper (DOI) ↗ -
iPSC Culture & Stem Cell Biology
Generating a Cost-Effective, Weekend-Free Chemically Defined Human Induced Pluripotent Stem Cell (hiPSC) Culture Medium
Read paper (DOI) ↗ -
Virology & Viral Vectors
Formulation and production of a blood-free and chemically defined virus production media for VERO cells
Read paper (DOI) ↗ -
iPSC Culture & Stem Cell Biology
Cross-Regulation between TDP-43 and Paraspeckles Promotes Pluripotency-Differentiation Transition
Read paper (DOI) ↗ -
Cardiomyocytes & Cardiac Models
Generation of human induced pluripotent stem cell-derived cardiomyocytes in 2D monolayer and scalable 3D suspension bioreactor cultures with reduced batch-to-batch variations
Read paper (DOI) ↗ -
Cardiomyocytes & Cardiac Models
Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Recapitulate the Predilection of Breast Cancer Patients to Doxorubicin–Induced Cardiotoxicity
Read paper (DOI) ↗ -
Cardiomyocytes & Cardiac Models
Chemically Defined Culture and Cardiomyocyte Differentiation of Human Pluripotent Stem Cells
Read paper (DOI) ↗ -
Cardiomyocytes & Cardiac Models
Derivation of Highly Purified Cardiomyocytes from Human Induced Pluripotent Stem Cells Using Small Molecule-modulated Differentiation and Subsequent Glucose Starvation
Read paper (DOI) ↗ -
Cardiomyocytes & Cardiac Models
Chemically defined generation of human cardiomyocytes
Read paper (DOI) ↗ -
iPSC Culture & Stem Cell Biology
Generation of Human iPSCs From Human Peripheral Blood Mononuclear Cells using Non-Integrative Sendai Virus in Chemically Defined Conditions
Read paper (DOI) ↗ -
Transferrin & Iron Biology
Transferrin-Mediated Cellular Iron Delivery
Read paper (DOI) ↗ -
Transferrin & Iron Biology
Biochemical and structural characterization of recombinant human serum transferrin from rice (Oryza sativa L.)
Read paper (DOI) ↗ -
Transferrin & Iron Biology
Characterization of transferrin receptor-mediated endocytosis and cellular iron delivery of recombinant human serum transferrin from rice (Oryza sativa L.)
Read paper (DOI) ↗ -
Transferrin & Iron Biology
The Long History of Iron in the Universe and in Health and Disease
Read paper (DOI) ↗ -
Other
The University of Kansas High-Throughput Screening Laboratory. Part II: enabling collaborative drug-discovery partnerships through cutting-edge screening technology
Read paper (DOI) ↗ -
Transferrin & Iron Biology
Expression, purification, and characterization of recombinant human transferrin from rice (Oryza sativa L.)
Read paper (DOI) ↗
Optiferrin® is built for these applications
Talk to Product Applications
Discuss your specific cell culture workflow.
InVitria’s Product Applications scientists are available to talk through cell type, medium, iron delivery, inclusion level, and scale.